Browsing Tag
SARS-CoV-
6 posts
How SARS-CoV-2 defeats the innate immune response
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation!Press and hold the buttonIf you believe this is an error, please contact our support team.2a02:4780:11:1216:0:30ec:e162:2 : 1e245ec2-7170-44fd-9e11-709e3442
How a SARS-CoV-2 virus protein damages the heart?
SARS-CoV-2 infection causes COVID-19. The presence of the virus in the cardiac tissue of patients with COVID-19 suggests this is a direct, rather than secondary, the effect of infection. People infected with COVID-19 are at a significantly higher risk for developing heart muscle inflammation, abnormal heart rhythms, blood clots, stroke, heart attacks, and heart failure
SARS-CoV-2 and vaccine uptake among First Nations, Inuit and Métis peoples in urban areas
Credit: Unsplash/CC0 Public Domain Despite prioritizing Indigenous populations for SARS-CoV-2 vaccinations, vaccine uptake was low among First Nations, Inuit and Métis Peoples in Toronto and London, Ontario, according to new research published in CMAJ (Canadian Medical Association Journal). As more than half of Indigenous Peoples in Canada live in urban areas, it is critical to…
Analysis of SARS-CoV-2 Reinfection Risk Shows Omicron COVID Variant Evades Immunity From Prior Infection
By American Association for the Advancement of Science (AAAS) March 15, 2022 Analysis of SARS-CoV-2 reinfection risk in South Africa reveals differences among variants of concern. The Omicron variant of SARS-CoV-2 evades immunity from prior infection, an analysis of routine surveillance data from South Africa indicates. Early in November 2021, South African scientists spotted SARS-CoV-2…
Mutations in SARS-CoV-2 spike protein receptor-binding domains may result in escape variants resistant to therapeutics and vaccines
The SARS-CoV-2 virus is continuously evolving and structural changes to the virus may impact the efficacy of antibody therapies and vaccines. A study publishing Feb. 17 in PLOS Pathogens by Anshumali Mittal at the University of Pittsburgh, USA and colleagues describes the structural and functional landscape of neutralizing antibodies against SARS-CoV-2 spike protein and discuss…
Origine du SARS-CoV-2 : la thèse de l’accident de laboratoire écartée par l’Institut Pasteur
Mais comment le coronavirus est-il apparu chez l'Homme ? Deux ans après le début de la pandémie, on ne sait toujours pas. Une publication de l'Institut Pasteur vient appuyer la thèse d'une transmission d'un animal, la chauve-souris, à l'Homme.Cela vous intéressera aussi [EN VIDÉO] Visitez la première ville «spécial Covid» auto-suffisante Un cabinet d’architecture espagnol a…